Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and ...

Co-founder and CEO Jareeporn Jarukornsakul built industrial parks developer WHA from the ground up. Now she's facing the ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

Also on Trump’s mind is the Federal Reserve. Its chair Jay Powell will on Wednesday unveil the US central bank’s decision on interest rates. The uncomfortable relationship between the president and ...

PRINCETON, N.J. - Soligenix, Inc. (NASDAQ:SNGX), a micro-cap biotech company with a market capitalization of $4.28 million, announced Tuesday it has successfully completed the transfer of ...

The transfer included optimizing and implementing a commercially viable, scalable production process for the active ingredient used in HyBryte and SGX302, topical formulations being developed to ...

The committee has alleged that it had information the former Pfizer executive, after going to work for British drugmaker GSK, told his colleagues that Pfizer had delayed announcing its Covid ...